Stocktoria

INTEGRA LIFESCIENCES HOLDINGS CORP IART

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1995-08-16 · LEI

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the grey zone. It does not currently pay a dividend. FY2025 revenue was $1.6B at a -31.6% net margin.

Chart by TradingView
41/100
Stocktoria Quality Score · grade D
5/9
Piotroski F — financial health
1.17
Altman Z″ — distress risk · grey
Dividend yield · no dividend
-3.24
Beneish M-score — earnings quality · low

Quality score trend · recomputed for each fiscal year

Piotroski F /9
5 4 5 5 7 7 7 5 4 5 2016201720182019202020212022202320242025
Altman Z″
3.08 1.80 2.52 2.42 3.04 3.21 3.48 3.08 1.72 1.17 2016201720182019202020212022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$17.38 as of 2026-08-01 · +14.9% 1y
$9.42$17.9652-wk

Beneish M-score: -3.24 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.

Market cap USD$1.5B
Net margin 5y avg-1%
Return on equity 5y avg-5.1%
Beta1.25
Employees4,427

Analyst price target

$17.43 +0.3% vs last
consensus: hold · 7 analysts
target range $11.00 – $27.00

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Revenue trend · last 10y · up

How it ranks in Manufacturing · percentile among 1957 companies

Piotroski Fstronger than 63%
Net marginstronger than 32%
Return on equitystronger than 29%
Revenue growthstronger than 38%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 5/9 tests passed

Altman Z″ components · grey zone

ComponentValue
Working capital / assets0.195
Retained earnings / assets0.118
EBIT / assets-0.137
Equity / liabilities0.408

Sector peers · similar-size Manufacturing companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
IARTINTEGRA LIFESCIENCES HOLDINGS CORP5/91.17+1.5%
MMSIMERIT MEDICAL SYSTEMS INC7/94.9333.3+11.8%
PENPenumbra Inc6/98.5970.1+17.5%
HAEHAEMONETICS CORP7/92.8536.1-2%
TFXTELEFLEX INC5/93.56+17.2%
EMBCEmbecta Corp.6/91.992.2-3.8%
ICUIICU MEDICAL INC/DE6/92.9-6.3%

All Manufacturing companies →

About INTEGRA LIFESCIENCES HOLDINGS CORP

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

FAQ

Is IART financially healthy?

INTEGRA LIFESCIENCES HOLDINGS CORP's Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the grey zone.

Does IART pay a dividend?

No, INTEGRA LIFESCIENCES HOLDINGS CORP does not currently pay a dividend.

How profitable is IART?

In FY2025, INTEGRA LIFESCIENCES HOLDINGS CORP had a net margin of -31.6% and a return on equity of -49.5%.

Is IART overvalued or undervalued?

INTEGRA LIFESCIENCES HOLDINGS CORP trades at about 20.7× trailing earnings — below its 10-year norm (10-year range 26.5×–94.9×, median 47.8×). Stocktoria reports the data, not buy/sell advice.

What is the analyst price target for IART?

The average Wall-Street price target for INTEGRA LIFESCIENCES HOLDINGS CORP is $17.43, about 0.3% above the recent price, from 7 analysts (consensus: hold).

Is IART a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on INTEGRA LIFESCIENCES HOLDINGS CORP: a Piotroski F-score of 5/9, an Altman Z″ in the grey zone. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.